Search clinical trials for: Inhaled NO delivered via INOpulse DS-C Device

Total 3 results

Bellerophon Pulse Technologies

Completed

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension

United States
Bellerophon Pulse Technologies

Completed

Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) (PAH)

Pulmonary Arterial Hypertension | Pulmonary Hypertension

United States, Canada
Bellerophon

No longer available

Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19

COVID-19 | Coronavirus Infection | Pneumonia, Viral

3

Subscribe